(Q40773740)

23 September 2017

title

A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). (English)

1 reference

23 September 2017

main subject

phase I clinical trial

0 references

0 references

1 reference

10

A S Fauci

1 reference

23 September 2017

1

H C Lane

1 reference

23 September 2017

R T Davey

2

1 reference

23 September 2017

S A Sherwin

3

1 reference

23 September 2017

H Masur

4

1 reference

23 September 2017

A H Rook

5

1 reference

23 September 2017

J F Manischewitz

6

1 reference

23 September 2017

G V Quinnan

7

1 reference

23 September 2017

P D Smith

8

1 reference

23 September 2017

M E Easter

9

1 reference

23 September 2017

publication date

1 July 1989

1 reference

Journal of Clinical Immunology

23 September 2017

published in

1 reference

23 September 2017

volume

9

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

351-361

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00918667

23 September 2017

exact match

0 references

cites work

Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients

1 reference

12 December 2020

Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma

1 reference

12 December 2020

Immunologic developments in AIDS--1985.

1 reference

12 December 2020

Human interferon as a therapeutic agent: a decade passes

1 reference

12 December 2020

Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters

1 reference

12 December 2020

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome

1 reference

12 December 2020

Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Antiretroviral therapy and immunologic reconstitution in AIDS.

1 reference

12 December 2020

Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon

1 reference

12 December 2020

Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation

1 reference

12 December 2020

Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma

1 reference

12 December 2020

In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.

1 reference

12 December 2020

Convenient assay for interferons

1 reference

12 December 2020

Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III.

1 reference

12 December 2020

Human host response to Giardia lamblia. I. Spontaneous killing by mononuclear leukocytes in vitro

1 reference

12 December 2020

Phase I trial of recombinant interferon gamma in cancer patients

1 reference

12 December 2020

Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome

1 reference

12 December 2020

NIH conference. The acquired immunodeficiency syndrome: an update

1 reference

12 December 2020

Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production.

1 reference

12 December 2020

Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome

1 reference

12 December 2020

Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma

1 reference

12 December 2020

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Pharmacokinetic study of partially pure gamma-interferon in cancer patients

1 reference

12 December 2020

Immunologic reconstitution in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Effect of intravenous recombinant gamma-interferon on the respiratory burst of blood monocytes from patients with AIDS

1 reference

12 December 2020

Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.

1 reference

12 December 2020

Herpesvirus Infections in the Acquired Immune Deficiency Syndrome

1 reference

12 December 2020

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

12 December 2020

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

1 reference

12 December 2020

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

1 reference

12 December 2020

Phase I study of multiple dose intramuscularly administered recombinant gamma interferon

1 reference

12 December 2020

A phase I trial of recombinant gamma interferon in patients with cancer

1 reference

12 December 2020

Interferons and antiviral activity

1 reference

12 December 2020

Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00918667

1 reference

Dimensions Publication ID

23 September 2017

1023588731

0 references

1 reference